Two-Factor Authentication: Access eRA Modules via login.gov

eRA is moving to two-factor authentication via login.gov, meaning that log-in will require something you know (password) and something you have (a phone or other device). This new log-in method, optional at first but which may be required later, is coming for users of eRA Commons, Commons Mobile, IAR and ASSIST.

The move is part of HHS’s Reinvent Grants Management Initiative to provide the applicant and grantee community the ability to log in to four different grants systems (eRA, Grants.gov, GrantSolutions and Payment Management System) using the same user name and password via login.gov.

Access to eRA modules via login.gov will be available from April 8. Use of login.gov will be initially optional (except for a pilot group of peer reviewers). This new type of log-in will be available along with other existing log-in methods.

STEP 1 — Click on the login.gov option on eRA Commons

  1. When you click on the login.gov option on the eRA Commons home screen, you will be redirected to https://login.gov/

Note: If you already have a login.gov user name and password, enter it. You will go directly to Step 3 below.

STEP 2 — Create a login.gov account

  1. Enter email address at login.gov
  2. Receive email verification
  3. Verify email address
  4. Create password
  5. Choose a primary authentication method – for instance, select phone
    1. Enter phone number
    2. Enter security code received by text message
    3. Set up is confirmed
  6. Set up a secondary authentication method – for instance, an authenticator app
    1. Scan barcode and enter authenticator code
    2. Set up is confirmed
  7. Your account creation at login.gov is confirmed. Click Continue to return to eRA Commons.

 STEP 3 — Associate your login.gov account with your eRA Commons account (one-time only)

  1. The eRA Commons mapping page is displayed. Enter your eRA credentials – user name and password – to associate your login.gov account with your eRA Commons account. You will only do this once.

YOU ARE DONE — You will be returned to eRA Commons. The next time you log into eRA Commons using login.gov, you will automatically be redirected to eRA Commons without having to log in again.

Notice of Funding Opportunity for NRCS’s Wetland Mitigation Banking Program for Federal fiscal year (FY) 2020

The US Department of Agriculture – Natural Resources Conservation Service (NRCS) is announcing the availability of up to $5 million in Wetland Mitigation Banking Program (WMBP) grant funds for the development and establishment of mitigation banks and banking opportunities solely for agricultural producers with wetlands subject to the Wetland Conservation Compliance provisions of the 1985 Food Security Act (as amended). WMBP is a competitive grants program accepting proposals from Federally Recognized Native American tribal governments, State and local units of government, for-profit entities, non-profits with and without 501(c)3 status with the IRS other than institutes of higher education (IHE), private IHEs, and public and State controlled IHEs.

Wetland mitigation banking is the restoration, creation or enhancement of wetlands for the purpose of compensating for unavoidable impacts to wetlands at another location. Wetland mitigation banking is commonly used to compensate for wetland impacts from development, but it also used for impacts from agriculture. Conservation compliance provisions for wetlands, commonly called Swampbuster provisions, aim to remove certain incentives to produce agricultural commodities on converted wetlands. Producers seeking benefits through most USDA programs must meet conservation compliance by filing form AD-1026, affirming they will not drain, dredge or fill wetlands in order to grow commodity crops. In situations where avoidance or on-site mitigation is challenging, the Farm Bill allows for off-site mitigation through mitigation banking.

Wetland mitigation banking is the restoration, creation or enhancement of wetlands for the purpose of compensating for unavoidable impacts to wetlands at another location. Wetland mitigation banking is commonly used to compensate for wetland impacts from development, but it also used for impacts from agriculture.

Based on NRCS data, proposals from the following States will receive priority consideration: Georgia, Illinois, Indiana, Iowa, Michigan, Minnesota, Nebraska, Ohio, South Dakota, and Wisconsin.


Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 Basic Experimental Studies with Humans Required)

This Funding Opportunity Announcement (FOA) invites applications from investigators who strive to expand their research trajectories through the acquisition of new knowledge and skills in the areas of basic psychological processes, sociological processes, and/or biomedical pathways—expertise that is beyond and enhances their current areas of expertise. The program will support career development experiences and a small-scale research project that will provide experienced investigators with the scientific competencies required to conduct independent research projects that more thoroughly investigate interrelationships among behavioral, biological, endocrine, epigenetic, immune, inflammatory, neurological, psychological, and/or social processes. Eligible candidates are independent investigators at mid-career faculty rank or level.

Applicants may propose research career development projects that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical and/or behavioral outcomes in humans to understand fundamental aspects of phenomena (see NOT-OD-18-212). These studies fall within the NIH definition of a clinical trial and also meet the definition of basic research. Types of studies that should submit under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of phenomena without specific application towards processes or products in mind. Applicants who plan to gain research experience within an existing clinical trial or basic experimental study with humans led by another investigator, or who propose to gain research experience in purely basic human or model animal research, or in data sciences, must apply to companion FOA, PAR-20-211, Independent Clinical Trials Not Allowed.

This Funding Opportunity Announcement is for basic science experimental studies involving humans, referred to in NOT-OD-18-212 as “prospective basic science studies involving human participants.” These studies fall within the NIH definition of a clinical trial and also meet the definition of basic research. Types of studies that should submit under this FOA include studies that prospectively assign human participants to conditions (i.e., experimentally manipulate independent variables) and that assess biomedical or behavioral outcomes in humans for the purpose of understanding the fundamental aspects of phenomena without specific application towards processes or products in mind.

Enhancing Science, Technology, Engineering, and Math Educational Diversity (ESTEEMED) Research Education Experiences (R25)

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research.

To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on:

  • Courses for Skills Development
  • Research Experiences

These will be geared toward undergraduate freshmen and sophomores from diverse backgrounds, including those from groups underrepresented in bioengineering or STEM fields relevant to bioengineering, such as engineering or the physical/computational sciences, which play key roles in biomedical technologies and innovation. The ESTEEMED program is intended to expose students to bioengineering research early in their college careers and interest them in potentially pursuing advanced studies in bioengineering or a related field. It will prepare students to join, in their junior and senior years, an honors program, supported by federal or institutional funds, that promotes STEM and entrance into a Ph.D. program. The ultimate goal is for the participants to pursue a Ph.D. or M.D./Ph.D. degree and a subsequent research career integrating engineering and the physical sciences with medicine and biology in academia or industry.

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp – Clinical Trial Not Allowed)

The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention hereby notify Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) holding specific types of research grants that funds are available for administrative supplements to enhance the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from diverse backgrounds, including those from groups that have been shown to be underrepresented in health-related research. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project.  Administrative supplements must support work within the scope of the original project.

This Funding Opportunity Announcement (FOA) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this FOA are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.   

Fostering diversity in the scientific research workforce is a key component of the NIH strategy to identify, develop, support and maintain the quality of our scientific human capital NOT-OD-20-031.

Every facet of the United States scientific research enterprise – from basic laboratory research to clinical and translational research to policy formation – requires superior intellect, creativity and a wide range of skill sets and viewpoints. NIH’s ability to help ensure that the nation remains a global leader in scientific discovery and innovation is dependent upon a pool of highly talented scientists from diverse backgrounds, including those from underrepresented groups, who will help to further NIH’s mission.

NIH’s ability to help ensure that the nation remains a global leader in scientific discovery and innovation is dependent upon a pool of highly talented scientists including those from underrepresented groups, and others who will help to diversify the workforce to help further NIH’s mission.

Research shows that diverse teams working together and capitalizing on innovative ideas and distinct perspectives outperform homogenous teams. Scientists and trainees from diverse backgrounds and life experiences bring different perspectives, creativity, and individual enterprise to address complex scientific problems. There are many benefits that flow from a diverse NIH-supported scientific workforce, including: fostering scientific innovation, enhancing global competitiveness, contributing to robust learning environments, improving the quality of the research, advancing the likelihood that underserved or health disparity populations participate in, and benefit from health research, and enhancing public trust.

In spite of tremendous advancements in scientific research, information, educational and research opportunities are not equally available to all. NIH encourages institutions to diversify their student, postdoctorate and faculty populations to enhance the participation of individuals from groups that are underrepresented in the biomedical, clinical, behavioral and social sciences.